acute lung injury, nosocomial infections, and systemic inflammatory response syndrome [1] [2] [3] . The mechanism of transfusion-related adverse effects is unknown. Experimental studies suggest that RBC storage duration is a risk factor for the occurrence of transfusion-related adverse events [4, 5] , although results of clinical studies on the influence of age of RBCs on outcome are conflicting [5] [6] [7] [8] . Previously, we found that the supernatant of a RBC product, but not the RBCs themselves, induce pulmonary inflammation in a rodent model, but the causative factor was not identified [5] .
Introduction
Despite having obvious benefits, red blood cell (RBC) transfusion also carries risks. In several patient populations, RBC transfusions have been associated with inflammatory conditions such as pernatant was isolated and centrifuged again. The EV-containing supernatant was snap frozen and stored at -80 ° C until further use. Just prior to whole blood stimulation, samples from both fresh ( 12 days old) and stored ( 35 days old) RBC bags were thawed and ultracentrifuged for 60 min at 50,000 × g, 4 ° C. Hereafter, the EV-free supernatant was isolated by pipetting of the upper supernatant fraction. The EV pellet was resuspended in supernatant. EVs were quantified using tunable resistive pulse sensing (TRPS; qNano; Izon Science Ltd, Christchurch, New Zealand), as described by van der Pol et al. [13] . In short, the concentration and size distribution of particles was measured using a NP200A nanopore. This nanopore was suitable for the detection of 100-400 nm particles. Samples were measured with 7 mbar pressure, 45 mm stretch, and 0.34 V. Samples were analyzed until 1,000 vesicles were counted. To calibrate size and concentration, carboxylated polystyrene beads (Izon Science Ltd) were sonicated for 10 s, diluted in PBS with 0.3 mmol/l sodium dodecyl sulfate, and analyzed immediately after dilution.
Whole Blood Stimulation
The response of blood leukocytes to RBC-derived EVs was determined in a whole blood stimulation system. After written informed consent was obtained, blood was drawn from healthy volunteers in 10 ml sodium heparin tubes using the BD Vacutainer system (BD Biosciences, Franklin Lakes, NJ, USA). Immediately after drawing, 250 μl of whole blood was 1: 1 diluted with RPMI, to which a fixed amount of 50 μl of supernatant from a RBC product was added. Blood was incubated with supernatant from a fresh or stored RBC product, either containing EVs or depleted from EVs. A positive control group was added by stimulation with lipopolysaccharides (LPS) (from Escherichia coli, Sigma St. Louis, MO, USA; 10 ng/ml), whereas stimulation with PBS served as a negative control. After 6 h of incubation at 37 ° C with 5% CO 2 , samples were centrifuged at 600 × g for 10 min at 4 ° C. Supernatant was stored at -80 ° C. Levels of TNF, IL-6, IL-8, and IL-10 were determined by ELISA according to the manufacturer's instructions (R&D Systems, Minneapolis, MN, USA).
In separate stimulation experiments, the dose response to EVs was investigated. Whole blood from healthy donors (250 μl) was stimulated with 250 μl supernatant samples from fresh and stored RBC bags, to which fixed consecutive concentrations of EVs were added. EVs were isolated as described above and resuspended in supernatant and diluted with supernatant to a fixed volume containing increasing numbers of EVs.
Statistical Analysis
Variables are expressed as medians and interquartile ranges. For comparisons, Kruskal-Wallis testing was done followed by Dunn's post test. Statistical significance level of 0.05 was taken. For the analyses, Graphpad Prism 5 (Graphpad Software, San Diego, CA, USA) was used.
Results

Whole Blood Samples
We obtained blood from 12 healthy volunteers, aged 24-45 years. Blood groups were mixed (4 times type A, 6 times type B, 2 times type O). One volunteer was excluded from analysis because of strongly elevated levels of cytokines in the plasma.
Fresh versus Stored Extracellular Vesicles
Supernatant from fresh RBC units (N = 12) contained 5.4 × 10 6 ± 1.6 × 10 6 /μl of EVs, which were around 255.4 ± 45 nm in size. The amount of EVs in supernatant from stored RBC units (N = 12) was higher, namely 7.27 × 10 7 ± 1.16 × 10 7 /μl, which were 232.7 ± 32 nm in size. The level of IL-6 in the supernatant did not differ between fresh (4.2 ± 1.4 pg/ml) and stored EV samples (3.5 ± 1.1 pg/ml; non-significant (NS)), nor the level of TNF (14.2 ± 7.2 vs. 8.7 ± 1.9 pg/ml; NS) and the level of IL-8 (3.2±.2 vs. 3.0 ± 0.1 pg/ml; NS). fig. 1) . The addition of EV-free supernatant from RBC units did not induce a cytokine response compared to the negative control, regardless of storage time. In contrast, the addition of supernatant containing EVs significantly increased levels of all cytokines compared to incubation with supernatant alone. Of note, incubation with stored EVs induced a significantly higher production of TNF (p < 0.05) and IL-6 (p < 0.05) compared to incubation with fresh EVs, whereas levels of IL-10 and IL-8 did not differ between fresh and stored EVs ( fig. 1 ).
Concentration Sequence
After having observed that supernatant with EVs from stored RBC units induced a stronger host response compared to an equal volume of supernatant with EVs from fresh RBC units, we determined whether the increased response was dependent on the amount of EVs or on alterations in RBC-derived microparticles as a result of storage time. A concentration sequence was performed with supernatant from fresh and stored RBC units with increasing number of EVs. When blood was stimulated with higher numbers of EVs, the production of TNF, IL-6 and IL-8 was more pronounced (p < 0.05) ( fig. 2) , indicating a dose-response relationship. In contrast, IL-10 production remained low at all numbers of EV. Furthermore, stored EVs induced a higher production of IL-6 and IL-8, but not of TNF, compared to equal amounts of fresh EVs ( fig. 2 ).
Discussion
Our study shows that RBC-derived EVs induce a strong proinflammatory host response, which in strength equals that of LPS.
In vitro, it was found before that RBC-derived EVs have chemokine binding capacity [14] . Here, we extend these findings with functional studies, showing that RBC-derived EVs can induce inflammation. Of note, a recent study found that both supernatant containing RBC-derived EVs as well as supernatant depleted from EVs have neutrophil priming capacity [15] . The explanation for these different results may be related to differences in processing and storage conditions of RBC units. Indeed, the amount of EVs from leukoreduced RBC units decreased during storage in that study [15] , whereas the amount of EVs from leukoreduced RBC units increased during storage in this study. Whether EVs are causal of the adverse effects associated with RBC transfusion in patients is not known, but evidence is emerging that EVs may have an effect on key players during a transfusion-related acute lung injury, including white blood cells and the endothelium. It was recently found that neutrophil-induced activation of pulmonary endothelial cells depended on the presence of plateletderived EVs [16] . Also, in experimental murine models, injection of RBC-derived EVs from stored RBC units was shown to exacerbate lung injury [17, 18] . In this study, it is not clear whether EVs have a direct effect on host response. In addition to EVs derived from blood bags, endogenous circulating EVs also appear to have pro-inflammatory properties. In an animal model of ischemia reperfusion injury, EVs from endothelium and inflammatory cells are shed into the circulation, which can subsequently promote neutrophil migration [19] . Moreover, we showed in an earlier investigation that in trauma patients endogenously circulating EVs can induce an inflammatory host response [20] . As the EVs in this study are derived from allogenic blood, inflammation may have been induced allogenously, but the EVs may also have caused an endogenous host response. The exact mechanism remains to be determined. In this study, the pro-inflammatory capacity of RBC-derived EVs is dose-dependent. As numbers of EVs increased during storage, EVs may be considered as a part of the RBC storage lesion. Given that incubation of EVs, but not the stored supernatant, induced inflammation, we think that EVs and not another soluble factor in the supernatant are causative in mediating host response.
Dose-dependent activation of the host response was also present with EVs derived from fresh RBC units, suggesting that EVs are pro-inflammatory regardless of storage time. This finding may have clinical relevance. If EVs from RBCs are related to adverse effects of transfusion, interventions aimed at decreasing EVs prior to transfusion, such as use of a cell saver, may improve outcome of RBC transfusion.
In conclusion, this study shows that EVs from both fresh and stored RBC bags illicit a strong inflammatory host response in recipients. This response depends both on the number of EVs as well as on changes of the EVs related to storage.
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